Arvinas (ARVN) Current Deferred Revenue (2017 - 2026)
Arvinas (ARVN) posted Current Deferred Revenue of $51.8 million for Q1 2026, down 63.3% from $141 million a year earlier and down 27.3% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas' Current Deferred Revenue came in at $71.3 million, down 54.4% from FY2024.
- Annual Current Deferred Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 26.3% (FY2020 to FY2025).
- In prior years, Arvinas' Current Deferred Revenue was $156.2 million in FY2024 (-4.2%), $163 million in FY2023 (-25.4%), $218.6 million in FY2022 (+6.0%) and $206.2 million in FY2021 (+828.8%).
- The Q1 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q2 2021.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last seven quarters, with an average decline of 30.9% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2021, with growth of 828.8%; the weakest was Q1 2026, with a decline of 63.3%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $71.3 million (Q4 2025), $87.7 million (Q3 2025) and $102.9 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arvinas | 505.42 Mn | -2.15 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 51.80 Mn |
| Dec 31, 2025 | 71.30 Mn |
| Sep 30, 2025 | 87.70 Mn |
| Jun 30, 2025 | 102.90 Mn |
| Mar 31, 2025 | 141.00 Mn |
| Dec 31, 2024 | 156.20 Mn |
| Sep 30, 2024 | 199.20 Mn |
| Jun 30, 2024 | 267.90 Mn |
| Mar 31, 2024 | 162.90 Mn |
| Dec 31, 2023 | 163.00 Mn |
| Sep 30, 2023 | 224.20 Mn |
| Jun 30, 2023 | 230.10 Mn |
| Mar 31, 2023 | 214.90 Mn |
| Dec 31, 2022 | 218.60 Mn |
| Sep 30, 2022 | 193.10 Mn |
| Jun 30, 2022 | 194.40 Mn |
| Mar 31, 2022 | 197.50 Mn |
| Dec 31, 2021 | 206.20 Mn |
| Sep 30, 2021 | 162.94 Mn |
| Jun 30, 2021 | 22.15 Mn |
API Access
Arvinas Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();